EP300 and acute myeloid leukemia: Taken together, these findings support the hypothesis that p300/CBP directly regulates FLT3 transcription by facilitating H3K27Ac recruitment to its promoter region, thereby accounting for the sensitivity of AML cells to p300/CBP inhibitors.